Redditux 100 & 500 100mg, 500mg Concentrate for solution for infusion
PDF Leaflet Revision Date: 31 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various B-cell malignancies and autoimmune diseases.
Dosage (summary)
375 mg/mu00b2 IV weekly for 4 doses; adjust for specific conditions.
Onset of Action / Duration
Onset: 30 mins, Duration: Varies by condition.
Special Populations
- Elderly: No dose adjustment
- Children: Safety not established
Pregnancy & Breastfeeding
Not recommended in pregnancy; avoid breastfeeding during and 12 months post-treatment.
Key Drug Interactions
- Caution with other monoclonal antibodies
- No significant interactions with fludarabine or cyclophosphamide
Contraindications
- Hypersensitivity to rituximab
- Active severe infections
- Severe heart failure
Common side effects
- Infusion-related reactions
- Infections
- Neutropenia
- Cardiovascular events
Counselling Points
- Premedicate with antihistamines and antipyretics
- Monitor for infusion reactions
- Avoid live vaccines
Serious warnings
- Risk of PML
- Tumor lysis syndrome
- Hepatitis B reactivation
- Severe skin reactions
Important Disclaimer
The Redditux 100 & 500 100mg, 500mg Concentrate for solution for infusion professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
